FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1401811000001106: Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24803901000001118 Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37907301000001112 Co-proxamol 32.5mg/325mg tablets (Actavis UK Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Is a Co-proxamol 32.5mg/325mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Is pack of Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has active ingredient Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has AMP Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has specific active ingredient Dextropropoxyphene hydrochloride true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Alpharma Limited) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start